Sr. Specialty Sales Professional
Mallinckrodt Pharmaceuticals
Summary
The Senior Specialty Sales Professional develops and executes strategic sales plans within an assigned territory by understanding customer goals, business needs, and market dynamics. This role builds trusted relationships, leverages strong business and product expertise, and effectively communicates the positioning of Keenova products to drive customer engagement and business growth.
Job description
Territory & Business Planning
- Develop and execute territory business plans to maximize growth and portfolio performance.
- Establish call objectives, customer priorities, and action plans aligned with business goals.
- Analyze territory opportunities and adjust strategies to optimize results.
Customer Engagement & Sales Execution
- Build trusted relationships with healthcare professionals and key stakeholders.
- Execute impactful sales calls using approved promotional materials and effective selling techniques to clearly communicate the benefits and risks of Keenova products.
- Deliver customer-focused solutions based on account needs and market dynamics.
- Achieve territory performance objectives and key sales metrics.
Account & Territory Management
- Maintain accurate customer records, call activity, and territory insights in CRM systems.
- Manage your business requirements within company policies.
- Complete required administrative activities, reporting, and expense management.
- Practice appropriate use of cross functional collaboration.
Product & Market Expertise
- Maintain advanced knowledge of disease states, therapies, products, and competitor offerings, if applicable.
- Stay informed on healthcare market trends, payer dynamics, and customer challenges.
- Participate in ongoing training and professional development programs.
- Apply insights to deliver meaningful, value-added customer interactions.
Compliance & Ethics
- Conduct all activities in compliance with FDA, PDMA, HIPAA, Keenova policies, and industry regulations.
- Uphold the highest standards of integrity, professionalism, and patient-focused decision-making.
Requirements
- Bachelor's degree
- Valid driver's license and ability to travel within the assigned territory
- High sense of urgency in particular with regards to customer service orientation
- 1+ years of proven pharmaceutical, specialty, or healthcare sales experience
- Buy and Bill/Specialty Pharmacy Experience
- Demonstrated success in achieving sales goals and growing customer relationships
- Approximately 30% or more overnight travel, depending on territory
- Ability to safely operate a motor vehicle
- Ability to lift and carry materials up to 10 pounds
Benefits
- Competitive pay
- Total rewards package
- Bonus eligible
Company overview
Mallinckrodt Pharmaceuticals is a global specialty pharmaceutical company founded in 1867 with headquarters in Dublin, Ireland, and operational headquarters in the United States. The company develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies across two main segments: Specialty Brands and Specialty Generics. The Specialty Brands segment focuses on autoimmune and rare diseases in areas such as neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology, as well as immunotherapy, neonatal respiratory critical care therapies, analgesics, and gastrointestinal products. The Specialty Generics segment includes specialty generic drugs and active pharmaceutical ingredients. Mallinckrodt is particularly known for its flagship product Acthar Gel, a naturally sourced complex mixture of adrenocorticotropic hormone analogs used to treat various autoimmune disorders and medical conditions known to cause inflammation. The company has approximately 1,001-5,000 employees worldwide and operates with a direct sales presence in roughly 50 countries. Mallinckrodt has faced significant legal challenges related to opioid litigation and pricing controversies surrounding Acthar Gel, leading to bankruptcy filings in 2020 and 2023. In 2025, the company announced a merger with Endo to create a larger, diversified pharmaceuticals leader.